机构:[1]Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, China四川大学华西医院[2]West China School of Medicine, Sichuan University, Chengdu, China四川大学华西医院[3]Department of Urology, People’s Hospital of Tibet Autonomous Region, Lhasa, China
This work was supported by the National Natural Science Foundation of China (Grant number: 81500522) and Science & Technology Department of Sichuan Province (Grant number: 2020YFS0090, 2020YFS0046).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类|3 区医学
小类|3 区泌尿学与肾脏学4 区肿瘤学
最新[2025]版:
大类|3 区医学
小类|3 区泌尿学与肾脏学4 区肿瘤学
第一作者:
第一作者机构:[1]Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, China[2]West China School of Medicine, Sichuan University, Chengdu, China[3]Department of Urology, People’s Hospital of Tibet Autonomous Region, Lhasa, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Zheng Lei,Ye Jianjun,Wang Qihao,et al.Creatinine-Cystatin C Ratio as a Promising Prognostic Biomarker in Patients With UTUC After Radical Nephroureterectomy[J].Clinical Genitourinary Cancer.2025,102352.doi:10.1016/j.clgc.2025.102352.
APA:
Zheng Lei,Ye Jianjun,Wang Qihao,Wu Qiyou,Chen Kai...&Bao Yige.(2025).Creatinine-Cystatin C Ratio as a Promising Prognostic Biomarker in Patients With UTUC After Radical Nephroureterectomy.Clinical Genitourinary Cancer,,
MLA:
Zheng Lei,et al."Creatinine-Cystatin C Ratio as a Promising Prognostic Biomarker in Patients With UTUC After Radical Nephroureterectomy".Clinical Genitourinary Cancer .(2025):102352